Chemoinformaics analysis of 2-Acetyl-1,6,8-trihydroxy-3-methylanthracene-9,10-dione
| Molecular Weight | 312.277 | nRot | 1 |
| Heavy Atom Molecular Weight | 300.181 | nRig | 19 |
| Exact Molecular Weight | 312.063 | nRing | 3 |
| Solubility: LogS | -4.613 | nHRing | 0 |
| Solubility: LogP | 3.793 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 41.2035 |
| nHD | 3 | BPOL | 14.6425 |
| QED | 0.593 |
| Synth | 2.604 |
| Natural Product Likeliness | 1.595 |
| NR-PPAR-gamma | 0.932 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.186 |
| Pgp-sub | 0.004 |
| HIA | 0.11 |
| CACO-2 | -5.369 |
| MDCK | 0.0000111 |
| BBB | 0.02 |
| PPB | 0.991413 |
| VDSS | 0.501 |
| FU | 0.0208669 |
| CYP1A2-inh | 0.925 |
| CYP1A2-sub | 0.142 |
| CYP2c19-inh | 0.082 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.579 |
| CYP2c9-sub | 0.23 |
| CYP2d6-inh | 0.188 |
| CYP2d6-sub | 0.158 |
| CYP3a4-inh | 0.631 |
| CYP3a4-sub | 0.119 |
| CL | 4.985 |
| T12 | 0.252 |
| hERG | 0.024 |
| Ames | 0.789 |
| ROA | 0.048 |
| SkinSen | 0.536 |
| Carcinogencity | 0.346 |
| EI | 0.948 |
| Respiratory | 0.082 |
| NR-Aromatase | 0.078 |
| Antiviral | Yes |
| Prediction | 0.834997 |